A carregar...

Relapse prevention: a cost-effectiveness analysis of brexpiprazole treatment in adult patients with schizophrenia in the USA

OBJECTIVE: This study used a decision-analytic framework to assess the cost-effectiveness of brexpiprazole vs comparator branded therapies for reducing relapses and hospitalizations among adults with schizophrenia from a US payer perspective. METHODS: An economic model was developed to assess patien...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clinicoecon Outcomes Res
Main Authors: Aigbogun, Myrlene S, Liu, Sizhu, Kamat, Siddhesh A, Sapin, Christophe, Duhig, Amy M, Citrome, Leslie
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6101022/
https://ncbi.nlm.nih.gov/pubmed/30147350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S160252
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!